Stay updated on Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page
- Check5 days agoChange DetectedOnly the revision labels changed: Revision: v3.3.4 was added and Revision: v3.3.3 was removed. No study content, eligibility criteria, or results information was modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a new publication citation for long-term efficacy and biomarker exploration (J Hepatol, 2025, online ahead of print) and updated the revision to v3.3.3. The older citation (v3.3.2) was removed.SummaryDifference0.2%

- Check56 days agoChange DetectedUpdated PubMed-related text to state that publications are auto-filled from PubMed and may not be about the study, and revised the version from v3.2.0 to v3.3.2; the older PubMed-generated wording was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page removed a government funding/operating-status notice, and this change does not affect the trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange DetectedStudy location label updated from 'Tainan City, Taiwan' to 'Tainan, Taiwan'. This affects how the site is identified and displayed for recruitment and documentation on the study page.SummaryDifference0.1%

- Check84 days agoChange DetectedNo significant changes detected between the two screenshots; the Study Details page for NCT03510871 remains unchanged in content and layout.SummaryDifference0.5%

Stay in the know with updates to Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.